CN-23 gaseous hydrocarbon steam reforming catalyst

Product name: CN-23 gaseous hydrocarbon steam reforming catalyst 
Category: Reforming Catalyst for Honeycomb-shaped & Tube-shell Heat Exchanged Reformer

Description: With nickel as the active component, alumina as the carrier, and rare earth oxide as the co-catalyst, CN-23 gaseous hydrocarbon steam reforming catalyst applies to the heat exchanged reformer in synthetic ammonia plant.
 

New advances in brain sensor - wireless, soluble

Researchers from abroad have developed a wireless brain sensor that can monitor intracranial pressure and temperature, but also can be absorbed by the body, to reduce surgical removal of routine monitoring of equipment. The researchers pointed out that the implant as such can be used to monitor patients with traumatic brain injury, but they think we can build a similar sensor can be absorbed for monitoring activities in the organ systems throughout the body, research published in the International the magazine Nature.

Researchers Rory KJ Murphy said, in recent years, electronic devices and the rapid development of medical devices, is currently the biggest obstacle we face is that the implant will often induce specific immune responses, which the patient or the existence of certain risks; but these devices for patients benefit is its will slowly dissolve over time, the use of such sensors can also reduce the solubility surgeon surgical removal of the equipment required, which greatly reduces the risk of infection and complications of the patients body.

In the United States there are about 50,000 people each year die from trauma, such as traumatic brain injury, when a patient enters the hospital for treatment, the doctor must be conducted in patients with intracranial pressure measurement, because of the increased intracranial pressure often lead to further brain damage and the current through the brain scans and clinical characteristics, doctors can not reliably determine the patient's intracranial pressure. The researchers pointed out, but the most commonly used devices are based on 1980s technology developed, these devices larger, use more cumbersome, but also in the intensive care unit with its need to connect an external monitor to use. The new sensor developed by the researchers of this article, which is mainly composed of a polylactic acid polyglycolic acid (PLGA) and a silicone composition, but it can transmit accurate pressure, temperature, and other parameters. With the design and development of advanced materials and equipment, researchers might develop a more accurate implant electronically, and thereby facilitate the clinician operation.
Bolise Co., Ltd.

NG108-15

Retinitis pigmentosa (RP) is a group of inherited disorders in which abnormalities of the photoreceptors (rods and cones) or the retinal pigment epithelium (RPE) of the retina lead to progressive visual loss. Stakeholders first experience defective dark adaptation or "night blindness," followed by a narrowing of the peripheral visual field and possibly a loss of central vision late in the course of the disease.

P3-X63-Ag8

Alzheimer's disease is associated with a dense accumulation of proteins in amyloid plaques in the brain containing fragments of amyloid-beta as the main component. If the development of amyloid plaques is responsible for neurodegeneration in Alzheimer's disease, a reduction in the formation of beta-amyloid and the progress of development may prevent the symptoms of the disease. Fragments of beta amyloid proteolytic processing of the amyloid precursor protein (APP) derivatives in neurons and the subsequent release of fragments in the extracellular space. APP is cleaved in the ER at residue 17 encoded by the activity of the alpha-secretase protease ADAM-10 and TACE. Beta-secretase activity, as recently identified BACE cleaves the N-terminus of beta-amyloid fragment. Gamma secretase cuts in the APP transmembrane domain at amino acids 40 and 42, the release of residues amyloid beta fragments 1-40 / 42 and short articles as ASP3 (residues 17-40 / 42), alpha secretase cleavage requires. The gamma-secretase activity requires the transmembrane protein presenilin-1, which is divided into an N-terminal fragment and C-terminal which are both required for the gamma-secretase activity. Mutations in presenilin-1 are genetically associated with familial forms of Alzheimer's disease, even supporting the role of APP processing to develop the disease. Inhibition of beta or gamma secretase can provide a mechanism to treat this disease. Other mechanisms altering the degradation of beta-amyloid and use of vaccines against amyloid beta aggregates to contain to remove.

Clear the "bad cholesterol"

Low-density lipoprotein cholesterol (LDL-C) is a form of cholesterol transport in the blood, commonly known as "bad cholesterol", the level of increase will increase the risk of coronary heart disease in the blood. Familial hypercholesterolemia (FH) an autosomal dominant genetic disease, whose patients from the early years began to appear in the blood will be abnormally high levels of LDL-C. Among them, the homozygous much more severe symptoms than heterozygotes: former plasma cholesterol levels 6-8 times higher than normal high; the latter plasma cholesterol concentration is 2 to 3 times normal. In addition, familial hypercholesterolemia atherosclerosis can also cause corneal bow and yellow tumors and other symptoms.

However, the launch of new drugs Amgen Repatha? (Generic name evolocumab) to the treatment of this disease has brought new solutions. ? Repatha is the world's first PCSK9 inhibitor class of lipid-lowering drugs (PCSK9: proprotein convertase subtilisin 9). PCSK9 in the human body can reduce the ability of the liver remove LDL-C in the blood, which in fact lead to elevated levels of the latter. Repatha? By binding to PCSK9, in order to prevent the latter to combine low-density lipoprotein cholesterol receptor (LDLR), thus inhibiting the LDLR degradation process mediated by the PCSK9, and promotes recycling of stem cells LDLR. Therefore, Repatha? Ultimately increase the number of liver cell surface used to clear the blood of "bad cholesterol" in the LDLR, played the role of lipid-lowering.

Repatha? Is a joint venture between Amgen and Anse Tektronix Japan established Amgen Astellas BioPharma KK R & D last year, has received FDA approval. And just last week, Repatha? Has finally been approved by the Japanese Ministry of Health, Labour and Welfare to market, for the treatment of familial hypercholesterolemia, as well as for HMG-CoA inhibitor drugs (statin, statin) is invalid and a high cardiovascular hypercholesterolemic patients the risk of disease. It became the first in Japan to be approved PCSK9 inhibitor class of lipid-lowering drugs.

Subvert the forefront of future military operations in biotechnology

Military Biotechnology is the application of modern biotechnology to a comprehensive cross-technology in the field of military technology, involving military, biology, physics, materials, information, and many other disciplines. Military biotechnology through numerous excellent reference and use of biological structure and special features, will achieve leapfrog innovation and development of weapons and equipment to provide a new source of weaponry has become an important driving force for change, and the continuous birth of a new form of combat and combat idea. In recent years, as the representative of the United States attaches great importance to the development of world military power military biotechnology, has made significant breakthroughs in many areas of biological materials, biomimetic and equipment, bio-computing, bio-fuels.

Biotechnology has become a new strategic high ground

Open historical picture is not difficult to find, change human warfare style of many major inventions were solidarity and biology of development and progress. For example, based on bird wings analysis, human design aircraft airfoil, and constantly promote the evolution of combat aircraft; by imitating the bat ultrasound, the invention of radar technology, the "telescope" is no longer a myth; reference dolphin ultrasonic detection, the invention of sonar technology, offer insight into the underwater world. Development of military biotechnology, will operate weapons, battlefield command, communications and logistics support qualitative change and leap, will become the commanding heights of military technology to provide new impetus to the development of conventional weaponry, including: military Biotechnology and Weaponry integration; military biotechnology will bring new weapons operating mode, weapons and equipment to promote "brain - machine combined with" direction; learn and use of biological numerous excellent structure and special features for weapons and equipment to achieve leapfrog innovation development of new sources; military biotechnology will improve battlefield awareness and information processing capabilities to provide new ways for the military logistical support.

Skirrow Agar Base

Product name:Skirrow Agar Base,Modified 
Packing(g/bottle):250

Application:
For the Isolation of Gonorrhoeae Campylobacter jejuni.

Formula: (g/L) 
peptone    15.0g
yeast powder    5.0g
Pancreatic casein peptone    2.5g
NaCL    5.0g
FeSO4    0.25g
Sodium metabisulphite     0.25g
sodium pyruvate    0.25g
agar    15.0g
PH     7.2-7.6